Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

257
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
257
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

133
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis.

Journal of addiction medicine·2026
Same author

Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): results of a 28-site cluster-randomized type 3 hybrid trial.

Implementation science : IS·2025
Same author

Data-Driven Contingency Management Incentive Magnitudes: A Review.

JAMA psychiatry·2025
Same author

A Call to Action: Evidence-Based Contingency Management.

The American journal of psychiatry·2025
Same author

Implementing a pre-exposure prophylaxis (PrEP) promotion intervention among persons who inject drugs: Perspectives from community and research implementation partners.

Journal of substance use and addiction treatment·2025
Same author

Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey.

Addiction science & clinical practice·2024

Related Experiment Video

Updated: Jul 29, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.8K

Implementing an evidence-based prize contingency management protocol for stimulant use.

Carla J Rash1

  • 1UConn Health School of Medicine, USA.

Journal of Substance Use and Addiction Treatment
|May 25, 2023
PubMed
Summary

This guide provides essential planning resources for implementing evidence-based prize contingency management (CM) for stimulant use disorders. It details best practices and modifications to ensure effective CM treatment delivery.

Keywords:
AdoptionCocaineFishbowl CMImplementationMethamphetamineMotivational incentives

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

10.6K

Related Experiment Videos

Last Updated: Jul 29, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.8K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

10.6K

Area of Science:

  • Addiction Medicine
  • Behavioral Health
  • Psychopharmacology

Background:

  • Contingency management (CM) is a proven treatment for stimulant use disorders.
  • Existing resources primarily support CM delivery, not its design and preparation.
  • Effective CM implementation requires careful planning and adherence to evidence-based practices.

Purpose of the Study:

  • To provide guidance on designing and preparing for the implementation of prize-based CM.
  • To offer a suggested prize CM protocol and discuss evidence-based best practices.
  • To highlight recommended and non-recommended modifications for CM programs.

Main Methods:

  • Outlines a suggested prize CM protocol.
  • Discusses evidence-based best practices and acceptable modifications.
  • Identifies non-evidence-based modifications to avoid.
  • Addresses practical and clinical aspects of CM preparation.

Main Results:

  • Provides a framework for evidence-based prize CM implementation.
  • Differentiates between recommended and non-recommended CM modifications.
  • Emphasizes the importance of proper planning for effective treatment.

Conclusions:

  • Poorly designed CM can negatively impact patient outcomes.
  • This guide supports programs in adopting evidence-based prize CM for stimulant use disorders.
  • Planning is crucial for successful CM program adoption and efficacy.